|
|
||||||||
Ann Thorac Surg 2006;82:28-33
© 2006 The Society of Thoracic Surgeons
a Department of Cardiac Surgery, Innsbruck Medical University, Innsbruck, Austria
b Department of Cardiology, Innsbruck Medical University, Innsbruck, Austria
c Department of Anesthesiology and Intensive Care Medicine, Innsbruck Medical University, Innsbruck, Austria
d Department of General and Transplantation Surgery, Innsbruck Medical University, Innsbruck, Austria
Accepted for publication February 27, 2006.
* Address correspondence to Dr Hoefer, Department of Cardiac Surgery, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria; (Email: daniel.hoefer{at}uibk.ac.at).
BACKGROUND: Patients with cardiogenic shock can be stabilized by percutaneous implantation of extracorporeal membrane oxygenation (ECMO). If weaning from ECMO is impossible, the implantation of a ventricular assist device (VAD) is required. Patients either go for recovery of myocardial function (bridge to recovery) or for heart transplantation (bridge to transplant).
METHODS: One hundred thirty-one patients were supported with ECMO between March 1995 and November 2005. Reasons for ECMO implantation were acute heart failure, acute or chronic heart failure, and postcardiotomy heart failure. In 28 patients, subsequent VAD implantation was necessary (bridge to bridge concept).
RESULTS: Fourteen bridge to bridge patients (50%) became long-time survivors with a mean follow-up of 39 months. Risk factors for mortality were status postcardiopulmonary resuscitation and elevated lactate and bilirubin levels before VAD implantation. Complications after ECMO and VAD implantation were bleeding and thromboembolic events. The most common cause of death was multiorgan failure.
CONCLUSIONS: Bridge to bridge is a successful concept for selected patients with cardiogenic shock. During ECMO support, patients can be evaluated for comorbidities. For patients with a combination of risk factors (status postcardiopulmonary resuscitation, elevated lactate levels, and impaired liver function), VAD implantation should be considered very carefully.
This article has been cited by other articles:
![]() |
M. Tajik and M. G. Cardarelli Extracorporeal membrane oxygenation after cardiac arrest in children: what do we know? Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 409 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Reynolds and J. S. Hochman Cardiogenic Shock: Current Concepts and Improving Outcomes Circulation, February 5, 2008; 117(5): 686 - 697. [Full Text] [PDF] |
||||
![]() |
E. Ruttmann, A. Weissenbacher, H. Ulmer, L. Muller, D. Hofer, J. Kilo, W. Rabl, B. Schwarz, G. Laufer, H. Antretter, et al. Prolonged extracorporeal membrane oxygenation-assisted support provides improved survival in hypothermic patients with cardiocirculatory arrest J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 594 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. John, K. Liao, K. Lietz, F. Kamdar, M. Colvin-Adams, A. Boyle, L. Miller, and L. Joyce Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 351 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Copeland Invited commentary. Ann. Thorac. Surg., July 1, 2006; 82(1): 33 - 34. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |